| P50 | author | Jung Goo Lee | Q53114618 |
| | Jong-Hyun Jeong | Q57012037 |
| P2093 | author name string | Won Kim | |
| | Young-Min Park | |
| | Se-Hoon Shim | |
| | Duk-In Jon | |
| | Kyung Joon Min | |
| | Won-Myong Bahk | |
| | Young Sup Woo | |
| | Jeong Seok Seo | |
| | Hee Ryung Wang | |
| P2860 | cites work | Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. | Q55052151 |
| | Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report | Q29615999 |
| | Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation | Q33411020 |
| | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care | Q34578945 |
| | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. | Q35560309 |
| | Desvenlafaxine for the acute treatment of depression: a systematic review and meta-analysis | Q35709303 |
| | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders | Q35862776 |
| | Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study | Q35965576 |
| | Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients | Q36514336 |
| | Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine? | Q36956511 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. | Q37197207 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments | Q37197216 |
| | Korean medication algorithm for depressive disorder: comparisons with other treatment guidelines | Q37617268 |
| | Therapeutic options in treatment-resistant depression | Q37881968 |
| | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders | Q38123516 |
| | Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation | Q38166873 |
| | The Korean Medication Algorithm for Depressive Disorder: second revision. | Q38227960 |
| | Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials | Q38377259 |
| | Vilazodone: a review in major depressive disorder in adults | Q38615116 |
| | Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed | Q38759204 |
| | LEVOMILNACIPRAN--A SUCCESSOR OF MILNACIPRAN WITH A HIGHER NORADRENERGIC SELECTIVITY. | Q38834826 |
| | Prevalence rates and clinical implications of bipolar disorder "with mixed features" as defined by DSM-5. | Q48161129 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | depressive disorder | Q11076418 |
| P304 | page(s) | 199-209 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | Q26842559 |
| P1476 | title | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines | |
| P478 | volume | 15 | |